Structure Therapeutics GPCR Balance Sheet (2022-2026)

NASDAQ GPCR
$47.34 +0.00 (+0.00%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Structure Therapeutics Quarterly Balance Sheet

Periods 18 quarters
Latest Jun 2026

Structure Therapeutics reported total assets of $1425.41M and total liabilities of $71.01M for the quarter ended Jun 2026, up 74.6% year over year. This balance sheet covers 18 quarters of results from Mar 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation 0.35M0.42M0.49M0.57M0.64M0.87M1.10M1.36M1.64M2.97M
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 83.74M240.90M224.60M205.40M461.97M436.40M927.10M915.30M875.34M836.90M786.50M799.00M1,441.66M1,458.50M1,342.70M
Receivables - NetNet Receivables 100.00M
Receivables - OtherOther Receivables 100.00M-100.00M
Receivables 200.00M
Prepaid Assets 2.25M5.29M3.63M4.54M6.29M12.91M10.50M8.37M7.69M12.74M12.80M14.98M24.11M32.09M29.37M
Current Assets 93.09M246.16M228.22M209.96M473.61M449.36M937.62M923.65M891.21M849.62M799.30M814.02M1,570.30M1,490.60M1,372.03M
Non-Current Assets
Property, Plant & Equipment (Net) 1.03M0.96M1.08M2.41M3.23M3.12M3.31M3.73M3.48M3.52M3.46M4.67M6.65M6.37M6.33M
Other Non-Current Assets 3.46M0.06M0.04M0.35M0.04M0.05M1.83M1.82M5.11M6.10M6.20M6.60M0.72M5.55M40.99M
Non-Current Assets 4.76M1.20M1.21M6.41M8.41M7.87M9.41M9.57M12.12M16.93M17.14M18.14M13.62M17.53M53.39M
Assets 97.84M247.35M229.43M216.37M482.02M457.23M947.03M933.22M903.33M866.55M816.44M832.16M1,583.92M1,508.12M1,425.41M
Liabilities
Current Liabilities
Accounts Payables 6.01M4.95M5.70M3.32M4.74M6.54M2.21M8.45M8.02M8.71M8.99M17.80M13.86M7.82M11.13M
Payables 6.01M4.95M5.70M3.32M4.74M6.54M2.21M8.45M8.02M8.71M8.99M17.80M13.86M7.82M11.13M
Accumulated Expenses 6.74M5.89M9.24M15.96M18.56M15.45M18.82M23.27M26.30M25.31M27.38M36.93M46.54M46.55M52.39M
Other Accumulated Expenses 1.82M1.90M2.25M2.56M4.72M3.29M3.31M4.92M5.46M6.47M9.68M6.57M12.40M8.35M17.35M
Current Leases 0.26M0.17M0.07M0.82M1.44M1.60M1.63M1.71M1.70M2.47M2.66M2.80M2.88M2.61M2.60M
Total Current Liabilities 13.01M11.00M15.01M20.09M24.74M23.59M22.66M33.43M36.02M36.49M39.03M57.53M63.28M56.98M66.11M
Non-Current Liabilities
Preferred Stock Liabilities 199.97M
Operating Leases 3.03M4.01M3.52M3.04M2.67M2.16M5.12M5.01M4.29M3.61M3.18M3.63M
Other Non-Current Liabilities 0.28M0.50M0.30M0.29M0.31M0.30M0.31M0.32M0.33M0.65M0.86M1.26M
Total Non-Current Liabilities 13.01M23.12M28.55M27.11M25.70M36.11M38.19M41.60M44.05M61.81M66.89M60.17M69.75M
Total Liabilities 77.23M92.10M103.91M13.01M11.00M15.01M23.41M29.05M27.41M26.00M36.42M38.49M41.91M44.36M62.14M67.54M61.03M71.01M
Shareholder's Equity
Common Equity -77.23M-92.10M-103.91M-115.14M236.35M214.41M192.96M452.97M429.82M921.03M896.80M864.84M824.64M772.08M770.02M1,516.38M1,447.09M1,354.40M
Liabilities and Shareholders Equity 97.84M247.35M229.43M216.37M482.02M457.23M947.03M933.22M903.33M866.55M816.44M832.16M1,583.92M1,508.12M1,425.41M
Retained Earnings -116.95M371.12M373.00M375.33M659.00M662.50M1,180.14M1,186.56M1,193.01M1,199.74M1,209.29M1,272.48M1,985.60M1,995.54M2,010.26M
Treasury Shares 24.70M32.86M32.86M67.02M